Polymorphic Lengths of Dinucleotide $(GT)^n$ Repeats in Upstream of Human nNOS Exon 1f Gene Play a Role in Modulating the nNOS Transcription: Clinical Implications

  • Shin, Mi-Kyung (Department of Pharmacology, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 Project) ;
  • Kim, Kyung-Nam (Department of Pharmacology, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 Project) ;
  • Kim, Chul-Eung (Department of Psychiatry, Inha University Hospital, College of Medicine, Inha University) ;
  • Lee, Sung-Keun (Department of Pharmacology, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 Project) ;
  • Kang, Ju-Hee (Department of Pharmacology, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 Project) ;
  • Park, Chang-Shin (Department of Pharmacology, Center for Advanced Medical Education, Inha University College of Medicine by BK-21 Project)
  • Published : 2008.03.31

Abstract

The expression of neuronal nitric oxide synthase (nNOS) is regulated by various spliced first exons (exon 1a-1i), sharing differentially common exon 2 in diverse human tissues. The highly complex structure and regulation of human nNOS gene gave limitations of information for the precise mechanism of nNOS regulation. In the present study, we report that the repeats of polymorphic dinucleotides $(GT)^nA(TG)^n$ repeats located in just upstream to the exon 1f in human nNOS gene play suppressive role in transcription, as shown in the characteristics of Z-DNA motif in other genes. In neuronal and trophoblast cells transfected transiently with luciferase construct without dinucleotide repeats at the 5'-flanking region of exon 1f in nNOS gene, the luciferase activity was increased markedly. However, the presence of the dinucleotide repeats dramatically suppressed the luciferase activity to the basal level, and which was dependent on the length of $(GT)^n$ and $(TG)^n$ repeats. More importantly, we found the polymorphisms in the length of dinucleotide repeats in human. Furthermore, we show for the first time here that there is a significant association of the lengths of polymorphic dinucleotide $(GT)^n$ and $(TG)^n$ repeats with the risk of schizophrenia.

Keywords

References

  1. Wang, Y., Newton, D. C. & Marsden, P. A. Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 13:21-43 (1999) https://doi.org/10.1615/CritRevNeurobiol.v13.i1.20
  2. Hall, A. V. et al. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 269:33082-33090 (1994)
  3. Wang, Y. & Marsden, P.A. Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 34:71-90 (1995) https://doi.org/10.1016/S1054-3589(08)61081-9
  4. Newton, D. C. et al. Translational regulation of human neuronal nitric oxide synthase by an alternatively spliced 5'-untranslated region leader exon. J Biol Chem 278:636-644 (2003) https://doi.org/10.1074/jbc.M209988200
  5. Boissel, J. P., Schwarz, P. M. & Forstermann, U. Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide 2:337-349 (1998) https://doi.org/10.1006/niox.1998.0189
  6. Wang, Y. et al. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc Natl Acad Sci 96:12150-12155 (1999)
  7. Naylor, L. H. & Clark, E. M. d(TG)n.d(CA) sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic Acids Res 25: 1595-1601 (1990)
  8. Rothenburg, S., Koch-Nolte, F., Rich, A. & Haag, F. A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity. Proc Natl Acad Sci 98:8985-8990 (2001)
  9. Itokawa, M. et al. Genetic analysis of a functional GRIN2A promoter $(GT)^n$ repeat in bipolar disorder pedigrees in humans. Neurosci Lett 345:53-56 (2003) https://doi.org/10.1016/S0304-3940(03)00501-9
  10. Lo, H. S., Hogan, E. L. & Soong, B. W. 5'-Flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan. J Neurol Sci 194:11-13 (2002) https://doi.org/10.1016/S0022-510X(01)00666-9
  11. Liou, Y. J. et al. No association between the neuronal nitric oxide synthase gene polymorphism and Alzheimer disease. Am J Med Genet 114:687-688 (2002) https://doi.org/10.1002/ajmg.10670
  12. Liou, Y. J., Tsai, S. J., Hong, C. J. & Liao, D. L. Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia. Schizophr Res 65:57-59 (2003) https://doi.org/10.1016/S0920-9964(02)00532-7
  13. Reif, A. et al. A neuronal nitric oxide synthase (NOS-1) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11:286-300 (2006) https://doi.org/10.1038/sj.mp.4001779
  14. Arking, D. E. et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38:644-651 (2006) https://doi.org/10.1038/ng1790